Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.
de Vries G, Tsolova S, Anderson LF, Gebhard AC, Heldal E, Hollo V, Cejudo LS, Schmid D, Schreuder B, Varleva T, van der Werf MJ. de Vries G, et al. Among authors: gebhard ac. BMC Public Health. 2017 Apr 19;17(1):334. doi: 10.1186/s12889-017-4216-9. BMC Public Health. 2017. PMID: 28424062 Free PMC article.
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). Mitnick CD, et al. Among authors: gebhard ac. PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016. PLoS One. 2016. PMID: 27223622 Free PMC article. Review.
Introducing bedaquiline: experiences from the Challenge TB Project.
Edwards CG, Wares DF, Dravniece G, Gebhard A, Tiemersma E, van der Grinten E, Gidado M, van Weezenbeek K. Edwards CG, et al. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1046-1053. doi: 10.5588/ijtld.19.0790. Int J Tuberc Lung Dis. 2020. PMID: 33126937
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients.
van de Berg SEJ, Pelzer PT, van der Land AJ, Abdrakhmanova E, Ozi AM, Arias M, Cook-Scalise S, Dravniece G, Gebhard A, Juneja S, Handayani R, Kappel D, Kimerling M, Koppelaar I, Malhotra S, Myrzaliev B, Nsa B, Sugiharto J, Engel N, Mulder C, van den Hof S. van de Berg SEJ, et al. BMC Public Health. 2021 Jul 16;21(1):1404. doi: 10.1186/s12889-021-11427-y. BMC Public Health. 2021. PMID: 34271884 Free PMC article.
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.
Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. Falzon D, et al. Eur Respir J. 2011 Sep;38(3):516-28. doi: 10.1183/09031936.00073611. Epub 2011 Aug 4. Eur Respir J. 2011. PMID: 21828024 Free article.
29 results